Analysis of platelet donors function before and after thrombapheresis using the platelet function analyzer PFA-100.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Thrombosis Research

• Publication date

  2001-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0049-3848(01)00219-5PMID 11323014
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alterations in cytoskeletal organization and tyrosine phosphorylation in platelet concentrates prepared by the buffy coat method

  2000cited by this paper
• Apheresis‐induced platelet activation:comparison of three types of cell separators

  2000cited by this paper
• Evaluation of the hemostatic function of stored platelet concentrates using the platelet function analyzer (PFA-100 ).

  1999cited by this paper
• Evaluation of the PFA-100® System in the Diagnosis and Therapeutic Monitoring of Patients with von Willebrand Disease

  1999cited by this paper
• Flow cytometric analysis of platelet function in stored platelet concentrates.

  1999cited by this paper
• Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases.

  1998cited by this paper
• PFA-100™ System: A New Method for Assessment of Platelet Dysfunction

  1998cited by this paper
• Prediction of the transfusion effect of platelet concentrates as measured by a model of primary hemostasis ex vivo.

  1997cited by this paper
• Evaluation of Platelet Function Using the in vitro Bleeding Time and Corrected Count Increment of Transfused Platelets

  1996cited by this paper
• Evaluation of Platelet Function Using the in vitro Bleeding Time and Corrected Count Increment of Transfused Platelets: Comparison between Platelet Concentrates Derived from Pooled Buffy Coates and Apheresis

  1996cited by this paper
• Description of an In Vitro Platelet Function Analyzer-PFA-100™

  1995cited by this paper
• Quality Control of Platelet Concentrates by the Thrombostat 4000

  1995cited by this paper
• Preliminary Data from a Field Trial of the PFA-100™ System

  1995cited by this paper
• [Determination of platelet aggregation of donor blood before and after thrombocytapheresis].

  1994cited by this paper
• Aggregation Response of Human Platelets Stored at 22 C as Platelet‐Rich Plasma

  1979cited by this paper

• A global assessment of hemostatic function of healthy allogeneic stem cell donors undergoing apheresis by rotational thromboelastometry

  2024cites this paper
• Increased platelet-leucocyte complexes do not result in coagulation activation in plateletpheresis donors

  2024cites this paper
• Effect of Frequency of Platelet Apheresis on Coagulation Function in Donors: A Prospective Cohort Study

  2019cites this paper
• The Double Hazard of Bleeding and Thrombosis in Hemostasis From a Clinical Point of View: A Global Assessment by Rotational Thromboelastometry (ROTEM)

  2018cites this paper
• Von Willebrand factor multimer structure is neither acutely nor chronically affected by plateletpheresis.

  2014cites this paper
• Thrombelastographic evaluation of the influence of 2-RBC apheresis on donor's coagulation system.

  2013cites this paper
• Influence of multicomponent apheresis on donors’ haematological and coagulation parameters, iron storage and platelet function

  2012cites this paper
• Apheresis donors and platelet function: inherent platelet responsiveness influences platelet quality

  2008cites this paper
• CHAPTER 28 – The Platelet Function Analyzer (PFA)-100

  2007cites this paper
• Plateletpheresis does not cause long‐standing platelet‐derived growth factor release into the donor blood

  2005cites this paper
• Platelet function abnormalities in qualified whole‐blood donors: effects of medication and recent food intake

  2004cites this paper
• Thrombapheresis causes a transient impairment of platelet responsiveness to epinephrine in healthy donors.

  2002cites this paper
• Clinical application of the PFA-100®

  2002cites this paper